alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 13

- 41331 Summary Calendar

UNITED STATES OF AMERICA,

Plaintiff

- Appellee

v.
ROBERTO ALFONSO RODRIGUEZ

- CLAUDIO , Defendant

- Appellant

Appeal from the United States District Court for the Southern District of Texas USDC No. 7:13

- CR

- 1241

- 1

Before DAVIS, CLEMENT and HAYNES, Circuit Judges. PER CURIAM: * The Federal Public Defender appointed to represent Roberto Alfonso Rodriguez

- Claudio has moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U. S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Rodriguez

- Claudio h a s not filed a response. We have reviewed counsel’s brief and the relevant portions of the record reflected therein. We concur with counsel’s assessment that the appeal

* Pursuant to 5 TH C IR

. R. 47.5 , the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED July 18, 2014 Lyle W. Cayce Clerk Case: 13-41331 Document: 00512704216 Page: 1 Date Filed: 07/18/201413

- 41331
presents no nonfrivolous issue for appellate review. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. See 5 TH C IR

. R. 42.2.

2 Case: 13-41331 Document: 00512704216 Page: 2 Date Filed: 07/18/2014
STATE of Louisiana v. Iren COOPER

NO. 2017-KO-1205

Supreme Court of Louisiana.

May 11, 2018

Denied.
### Request for Information Andr ew T. Rock (FAA-2015-3201) 9-AWA-AVS-333Exemptions (FAA)

Dear Mr. Rock:
This letter is to inform you that the following information is miss ing from your petition (Docket No. FAA

− 2015

− 3201). This information is necessary for the Fe deral Aviation Administrati on (FAA) to process your p etition.

 Provide a copy of the Motion Picture and Television Op erations Manual (MPTOM) which is required by Order 8900.1, Volume 3, Chapter 8, Section 1. If you wish for us to proceed without this manual and remove closed

- set filming from your proposed operati on please inform of us of your intention by the requested response date listed below.
Please submit the additional information (non- proprietary) to your docket at www.regulations.gov . Once your information has been submitted, pl ease also send a copy of the requested information (and any proprietary information), as well as your comment tracking number from regulations .gov via e-mail to 333exemptions@faa.gov. I f you want us to process your request any further, we must receive the information de scribed above by November 19, 2015. If we do not receive the in formation, we will close the doc ket without notifying you further.
If you have any questions, please feel free to contact me at (202) 267-2999 .

FAA Office of Rulemaking Sent: Thursday, November 05, 2015 1:45 PM To: atrock85@yahoo.com
ex10_4.htm


 Exhibit 10.4
II 

112TH CONGRESS 

2D SESSION S. 2987 

To suspend temporarily the duty on phosphonic acid, maleic anhydride sodium 

salt complex. 

IN THE SENATE OF THE UNITED STATES 

MAY 8, 2012 

Mr. MENENDEZ introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To suspend temporarily the duty on phosphonic acid, maleic 

anhydride sodium salt complex. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PHOSPHONIC ACID, MALEIC ANHYDRIDE SO4 DIUM SALT COMPLEX. 

5 (a) IN GENERAL.—Subchapter II of chapter 99 of 

6 the Harmonized Tariff Schedule of the United States is 

7 amended by inserting in numerical sequence the following 

8 new heading: 

‘‘ 9902.01.00 Phosphonic acid, maleic anhydride sodium salt complex 

(CAS No. 180513–31–9) 

(provided for in subheading 

3824.90.92) ........................... Free No change No change On or before 

12/31/2015 ’’. 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 2987 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS
Information Requested from the Roxboro Steam Station 

1. Please provide the type and source (i.e., mine name and location) of coal used at the plant each day 

from January 2012 through December 2013. In addition, please provide the sulfur and chlorine 

content of the coal used at the plant for each day of this period, if available. For days where coal 

blending occurred, please note the percentage of each type of coal used. 

Response: 

Only monthly average sulfur content (% As_Received) and SO2 (lbm/Mbtu) is recorded. This 

information is provided in the “Roxboro EPA Data 3_14_14” spreadsheet on tab “SEO4643A4-

Mayo”. 

2. Please provide the following information for each day, beginning with the earliest date of sampling 

data you have provided through the end of 2013 (i.e., September 2009 through December 2013, if 

available: 

a) Chloride concentration, pH, and average daily oxidation-reduction potential (ORP) values within 

each FGD scrubber system;

Response: 

Average daily chloride concentration, pH and ORP values within each FGD scrubber system are 

provided in the “Roxboro EPA Data Final 3_14_14” spreadsheet under tab “FGD System 

Information”. These measurements are taken off the absorber. Roxboro consists of four units, each 

will serviced by its own absorber. 

b) Chloride concentration, pH, and average daily ORP values for the influent to the FGD wastewater 

treatment system; and 

Response: 

The FGD wastewater treatment system consists of a settling basin followed by a bioreactor. Chloride 

concentration is not measured in the influent to the settling basin. There are no reliable 

measurements of ORP or pH on the influent to the settling basins. 

Chloride concentration is not measured in the influent to the bioreactor. pH and average daily ORP 

values are measured in the influent to the bioreactor. This information is provided in the “Roxboro 

EPA Data Final 3_14_14” spreadsheet under tab “Bioreactor Influent”. 

c) Electric generation output (MW -hr) for each generating unit serviced by a FGD system.

Response: 

The electric generation output (MW-hr) for each generation unit serviced by a FGD system is 

provided in the “Roxboro EPA Data Final 3_14_14” spreadsheet under tab “Electricity 

Generation”.
Exhibit 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Horizon
Lines, Inc. (the Company) on Form 10-K for the period ending December 24, 2006 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, M. Mark Urbania, Senior Vice President and Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



|(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                                                               
|-----------------------------------------------------------------------------------------------
|/s/    M. MARK URBANIA                                                                         
|                                                                                               
|M. Mark Urbania Senior Vice President and Chief Financial Officer (Principal Financial Officer)
|                                                                                               
|March 2, 2007
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2833 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2833

  To suspend temporarily the duty on alginic acid, ammonium alignate, 
     potassium alginate, calcium alginate, and magnesium alginate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

  Ms. Collins introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To suspend temporarily the duty on alginic acid, ammonium alignate, 
     potassium alginate, calcium alginate, and magnesium alginate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALGINIC ACID, AMMONIUM ALIGNATE, POTASSIUM ALGINATE, CALCIUM 
              ALGINATE, AND MAGNESIUM ALGINATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.--.--      Alginic acid (CAS   Free         No change        No change        On or before 12/  ''.
                        No. 9005-32-7),                                                    31/2015.......
                        ammonium alignate
                        (CAS No. 9005-34-
                        9), potassium
                        alginate (CAS No.
                        9005-36-1),
                        calcium alginate
                        (CAS No. 9005-35-
                        0), and magnesium
                        alginate (CAS No.
                        37251-44-8)
                        (provided for in
                        subheading
                        3913.10.00)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Exhibit 32.2

Statement of Chief Financial Officer

Pursuant to Section 1350 of Title 18 of the United States Code

Pursuant to Section 1350 of Title 18 of the United States Code as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, the undersigned, James D. Brown, the Chief Financial Officer of NutriSystem, Inc. (the Company), hereby certifies that based on the undersigneds knowledge:



| | 1) | The Companys Form 10-Q Quarterly Report for the period ended June 30, 2006 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                      |  |                                                                           
|--------------------- |  | --------------------------------------------------------------------------
|Dated: August 8, 2006 |  | /S/ JAMES D. BROWN                                                        
|                      |  | Executive Vice President, Chief Financial Officer, Secretary and Treasurer
|                      |  | (Principal Financial Officer)
exv10w6



 





Exhibit 10.6




Base Salaries for Executive Officers




     On January 29, 2008, the Compensation Committee of the Board of Directors of Quiksilver, Inc.
(the “Company”) approved a reduction in the annual base salaries (effective as of February 1, 2008)
for the Company’s executive officers. The following table sets forth the reduced annual base salary
levels of the Company’s executive officers:



	 	 	 	 	 
	Name and Position	 	Base Salary
	Robert B. McKnight, Jr.,
	 	$	950,000	 
	Chief Executive Officer
	 	 	 	 
	Bernard Mariette,
	 	$	800,000	 
	President
	 	 	 	 
	Charles S. Exon,
	 	$	425,000	 
	Executive Vice President, Chief Administrative
Officer, Secretary and General Counsel
	 	 	 	 
	Joseph Scirocco,
	 	$	550,000	 
	Executive Vice President and Chief Financial Officer
	 	 	 	 
	David Morgan,
	 	$	475,000	 
	Executive Vice President and Chief Operating Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2623 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2623

    To suspend temporarily the duty on 4-chloro-3-nitrobenzoic acid.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Mr. Lieberman introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To suspend temporarily the duty on 4-chloro-3-nitrobenzoic acid.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 4-CHLORO-3-NITROBENZOIC ACID.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      4-Chloro-3-         Free         No change        No change        On or before 12/  ''.
                        nitrobenzoic acid                                                  31/2015.......
                        (CAS No. 96-99-1)
                        (provided for in
                        subheading
                        2916.39.08)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
# Official Journal C 241/2023

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 241 |
| | |
| English edition | Information and Notices | Volume 667 July 2023 |

ISSN 1977-091X

Official Journal

of the European Union

C 241

English edition

Information and Notices

Volume 667 July 2023

---

| Contents | page |
| --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2023/C 241/01 | Non-opposition to a notified concentration (Case M.11163 – TRAFIGURA / MOTA-ENGIL / LAH / JV) (
  1
  ) | 1 |

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2023/C 241/01

Non-opposition to a notified concentration (Case M.11163 – TRAFIGURA / MOTA-ENGIL / LAH / JV) (
  1
  )

1

1

---

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2023/C 241/02 | Euro exchange rates – 6 July 2023 | 2 |
| 2023/C 241/03 | Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
  (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006
  )

   (
  1
  ) | 3 |
| 2023/C 241/04 | Explanatory Notes to the Combined Nomenclature of the European Union | 4 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2023/C 241/02

Euro exchange rates – 6 July 2023

2

2023/C 241/03

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
  (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006
  )

   (
  1
  )

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006

)

1

3

2023/C 241/04

Explanatory Notes to the Combined Nomenclature of the European Union

4

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN
EXHIBIT 32


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Ardent Acquisition Corporation (the
"Company") on Form 10-KSB for the period ended December 31, 2005 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), each
of the undersigned, in the capacities and on the dates indicated below, hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

1.       The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and


2.       The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation of the
Company.


April 10, 2006                              By: /s/ Barry J. Gordon
                                                -------------------
                                            Barry J. Gordon
                                            Chairman and Chief Executive Officer


April 10, 2006                              By: /s/ Marc H. Klee
                                                ----------------
                                            Marc H. Klee
                                            President, Chief Financial Officer
                                            and Secretary
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 96-2091
SEYMORE SMITH, Plaintiff - Appellant, versus T. G. SHANE; BILLY VANDIFORD; SANDRA GASKINS; LOUISE W. FLANAGAN, in their Official and Individual Capacities, Defendants - Appellees.
Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. Malcolm J. Howard, District Judge. (CA-96-68-H-4) Submitted: February 27, 1997 Decided: March 10, 1997 Before MURNAGHAN, NIEMEYER, and MOTZ, Circuit Judges. Affirmed by unpublished per curiam opinion. Seymore Smith, Appellant Pro Se. Cheryl A. Marteney, WARD & SMITH, P.A., New Bern, North Carolina, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM:Appellant appeals the district court's order quashing a summons and remanding this action to state court pursuant to 28 U.S.C. § 1447(c) (1994). We have reviewed the record and the districtcourt's opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Smith v. Shane , No. CA-96-68-H-4 (E.D.N.C. July 10, 1996). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                                          0000753557                   
<NAME>                                         LBO Capital Corp.
<MULTIPLIER>                                   1
<CURRENCY>                                     US Dollars
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 APR-01-1998
<PERIOD-END>                                   JUN-30-1998
<EXCHANGE-RATE>                                1
<CASH>                                         35
<SECURITIES>                                   69,994
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               70,029
<PP&E>                                         0
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 70,029
<CURRENT-LIABILITIES>                          613,393
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       1,210
<OTHER-SE>                                     (544,574)
<TOTAL-LIABILITY-AND-EQUITY>                   70,029
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  1,166
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             26,525
<INCOME-PRETAX>                                (27,691)                         
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (27,691)
<EPS-PRIMARY>                                  (0.00)
<EPS-DILUTED>                                  (0.00)
        

</TABLE>
----

|   | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------|

|  /s/ Richard W. McCullough                    |   | August 20, 2010 |
|----------------------------------------------------|--------|-----------------|
| Richard W. McCullough                              |   |
| Chief Executive Officer                            |   |
| Petroleum Development Corporation (dba PDC Energy) |   |
| Managing General Partner                           |   |

|  /s/ Gysle R. Shellum                         |   | August 20, 2010 |
|----------------------------------------------------|--------|-----------------|
| Gysle R. Shellum                                   |   |
| Chief Financial Officer                            |   |
| Petroleum Development Corporation (dba PDC Energy) |   |
| Managing General Partner                           |   |

----